Shoukhrat Mitalipov
PersonMentions
2
Relationships
1
Events
2
Documents
1
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
Event Timeline
Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
1 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Unnamed Scientist
|
Professional team lead |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Creation of human embryos (genetic copies) for stem cell harvesting. | Oregon Health & Science Uni... | View |
| 2025-11-19 | N/A | Methods detailed in the journal Cell. | Journal Cell | View |
HOUSE_OVERSIGHT_027025.jpg
This document is a news article or report describing a scientific breakthrough at Oregon Health & Science University (OHSU) led by biologist Shoukhrat Mitalipov. The team successfully created human embryos using somatic cell nuclear transfer to harvest stem cells, a process that could treat diseases but also raises ethical concerns regarding human cloning. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it is part of a larger congressional investigation, likely related to Jeffrey Epstein's known interest in transhumanism and cloning, although he is not explicitly named in this specific page.
News article / scientific report summary
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity